CF Acquisition Corp. IV Announces Special Meeting of Stockholders to be held at 4:00 p.m. on December 22, 2022 and That Trust Account Will Bear Interest and Will Not Be Decreased Due to Excise Tax
— 21 December, 2022
Press Releases
Cantor Fitzgerald & Co. served as Placement Agent on a private placement of $200 million Senior Unsecured Convertible Notes for View, Inc.
— 27 October, 2022
KOL Lunch - Cantor Fitzgerald’s Neurology & Psychiatry Conference
Senior Biotech Analyst Charles
— 14 October, 2022
Broken Circuits – Modulating the Neuroendocrine Systems to Re-Establish Equipoise
Senior Biotech Analyst
— 14 October, 2022
Tackling Neurocognitive/ Neurodegenerative Diseases – New Targets & Platforms
Biotech Analyst
— 13 October, 2022
Next Generation Drugs. New Targets and Innovative Approaches for High-unmet Need Epileptic Disorders
Vice President and Biotech Analyst
— 13 October, 2022
ALS -New Treatment Paradigm with More MoAs on the Way?
Senior Biotech Analyst,
— 12 October, 2022
Diverse MoAs in Depression Don’t Make Us Depressed
Vice President and Biotech Analyst,
— 11 October, 2022
Tripping Our Way to a New Treatment Paradigm for Psychiatric Disorders – Intermittent Therapy vs. Chronic Treatment.
Senior Biotech Analyst
— 11 October, 2022
KOL Lunch - Cantor Fitzgerald’s Neurology & Psychiatry Conference
Thank you to all who joined Cantor’s
— 11 October, 2022
Multiple Myeloma & Lymphoma
“Multiple Myeloma & Lymphoma”
— 7 October, 2022
New Drug Discovery, Development & Manufacturing Platforms
“New Drug Discovery, Development
— 7 October, 2022